Anti-CD4 and anti-CD8 IHC stainings showed that although YM101 had a modest effect on the number of CD4+ and CD8+ T cells in the peritumoral stroma (Fig. 7g, h), YM101 markedly increased the quantity of T cells in tumor center (Fig. 7g, h). The gene discussed is CD8A; the disease is neoplasm.